We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$104B
AUM Growth
+$8.72B
(+9.1%)
Cap. Flow
-$256M
Cap. Flow
% of AUM
-0.25%
Top 10 Holdings %
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$35.4M |
| 2 |
P
Everpure Inc
P
|
+$21M |
| 3 |
NVIDIA
NVDA
|
+$20.7M |
| 4 |
American Homes 4 Rent
AMH
|
+$19.3M |
| 5 |
DAY
Dayforce
DAY
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$46.7M |
| 2 |
Apple
AAPL
|
+$41.8M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$32.3M |
| 4 |
Gilead Sciences
GILD
|
+$27.8M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$25.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.42% |
| 2 | Financials | 13.09% |
| 3 | Healthcare | 11.94% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
BARK
BARK
$101M
| $164K | ﹤0.01% |
6,608
+196
| +3% | +$4.3K |
|
3052
Dakota Gold
DC
$804M
| $163K | ﹤0.01% |
68,941
+614
| +0.9% | +$1.33K |
|
|
SBT
3053
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $163K | ﹤0.01% |
31,542
+1,031
| +3% | +$5.37K |
|
3054
Harvard Bioscience
HBIO
$29.2M
| $162K | ﹤0.01% |
3,824
+166
| +5% | +$7.46K |
|
|
WW
3055
DELISTED
WW International
WW
| $161K | ﹤0.01% |
87,226
+1,081
| +1% | +$4.3K |
|
3056
CGI
GIB
$15.5B
| $160K | ﹤0.01% |
1,450
+130
| +10% | +$14.5K |
|
3057
Sun Life Financial
SLF
$45.4B
| $160K | ﹤0.01% |
2,931
+25
| +0.9% | +$1.32K |
|
|
B
3058
Barrick Mining
B
$73.2B
| $160K | ﹤0.01% |
9,610
-187
| -2% | -$2.92K |
|
3059
Virginia National Bankshares
VABK
$260M
| $160K | ﹤0.01% |
5,308
-300
| -5% | -$9.52K |
|
|
AKYA
3060
DELISTED
Akoya BioSciences
AKYA
| $159K | ﹤0.01% |
33,857
+798
| +2% | +$4.14K |
|
|
AV
3061
DELISTED
Aviva Plc
AV
| $158K | ﹤0.01% |
12,440
+45
| +0.4% | +$572 |
|
3062
JFrog
FROG
$10.8B
| $158K | ﹤0.01% |
3,574
+100
| +3% | +$3.87K |
|
3063
Rackspace Technology
RXT
$1.24B
| $157K | ﹤0.01% |
99,092
-1,327
| -1% | -$2.38K |
|
3064
The ONE Group
STKS
$53M
| $156K | ﹤0.01% |
27,929
-209
| -0.7% | -$916 |
|
|
TGAN
3065
DELISTED
Transphorm, Inc. Common Stock
TGAN
| $155K | ﹤0.01% |
31,663
+1,146
| +4% | +$5.44K |
|
3066
Chemung Financial Corp
CHMG
$392M
| $155K | ﹤0.01% |
3,640
+144
| +4% | +$6.47K |
|
|
GRSD
3067
Grandstand Limited Ordinary Shares
GRSD
$67M
| $154K | ﹤0.01% |
16,907
+1,227
| +8% | +$11.1K |
|
3068
Genelux
GNLX
$119M
| $154K | ﹤0.01% |
23,999
+924
| +4% | +$8.39K |
|
3069
Sight Sciences
SGHT
$412M
| $154K | ﹤0.01% |
29,140
+1,318
| +5% | +$6.2K |
|
3070
Outset Medical
OM
$90.8M
| $153K | ﹤0.01% |
4,608
+178
| +4% | +$9.01K |
|
3071
Lexeo Therapeutics
LXEO
$378M
| $153K | ﹤0.01% |
+9,730
| New | +$152K |
|
3072
Weibo
WB
$1.95B
| $152K | ﹤0.01% |
16,749
+2,458
| +17% | +$22.3K |
|
3073
Eos Energy Enterprises
EOSE
$1.51B
| $152K | ﹤0.01% |
147,375
+11,924
| +9% | +$12.1K |
|
3074
ClearPoint Neuro
CLPT
$433M
| $151K | ﹤0.01% |
22,202
+1,110
| +5% | +$7.76K |
|
3075
LiveWire
LVWR
$221M
| $151K | ﹤0.01% |
20,865
+1,224
| +6% | +$11.7K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2024 Portfolio in Review
As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3%. RhumbLine Advisers opened 62 new positions and exited 71, leaving the 4,372-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
- RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
- RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
- RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
- RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
- RhumbLine Advisers opened 62 new positions and closed 71 in Q1 2024.
- RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.
Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.